Perspectives on biologically active camptothecin derivatives

Area of Science:

• Natural Products Chemistry
• Medicinal Chemistry
• Pharmacology

Background:

• Camptothecins (CPTs) are cytotoxic alkaloids discovered in the late 1960s.
• Research has evolved from natural product isolation to synthetic derivatives, formulations, and macromolecular constructs.
• Three CPT derivatives (topotecan, irinotecan, belotecan) are approved anticancer drugs, with others in clinical trials.

Purpose of the Study:

• To provide a comprehensive overview of the diverse biological activities of camptothecin derivatives.
• To update coverage on the anticancer effects of CPTs.
• To explore emerging non-anticancer biological activities of CPTs.

Main Methods:

• Literature review of camptothecin research.
• Analysis of medicinal chemistry efforts in generating CPT derivatives.
• Synthesis of information on clinical trial status and biological effects.

Main Results:

• Numerous CPT derivatives have been synthesized through extensive medicinal chemistry.
• Topotecan, irinotecan, and belotecan are established anticancer agents.
• Growing interest and publications indicate expanding research into other biological effects of CPTs.

Conclusions:

• Camptothecins exhibit significant anticancer properties, with several derivatives in clinical use and development.
• The scope of camptothecin research is expanding beyond oncology to encompass other biological activities.
• Continued investigation into CPT derivatives promises novel therapeutic applications.